“…Many immunopotentiators have been developed as immunotherapeutic agents, such as tubercle bacilli (39), hemolytic streptococci (26), Corynebacterium (37), polysaccharides prepared from basidiomycetes (8,13,19,36), plants (27) and yeasts (9), and levamisole (25); some of them have been used clinically with promising results. These agents are shown to induce interferon in the sera of experimental animals (17,(22)(23)(24) and some have been shown to induce interferon in patients with cancer. Such interferon is considered to be a type of immune interferon, because it is very unstable to heat and acid treatment and is produced by immunocompetent cells (17,22).…”